(C57BL/6J x B10.Cg-H2k Tg(Cd74-rtTA)#Doi Tg(tetO-Cd74/MCC)#Doi)F1/Ieg

Status

Available to order

EMMA IDEM:05574
International strain name(C57BL/6J x B10.Cg-H2k Tg(Cd74-rtTA)#Doi Tg(tetO-Cd74/MCC)#Doi)F1/Ieg
Alternative nameIi-rTAxTIM
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Cd74-rtTA)#Doi, Tg(tetO-Cd74/MCC)#Doi
Gene/Transgene symbolTg(Cd74-rtTA)#Doi, Tg(tetO-Cd74/MCC)#Doi

Information from provider

ProviderReinhard Obst
Provider affiliationInstitute for Immunology, Ludwig-Maximilians-Universität Munich
Additional ownerChristophe Benoist, Department of Microbiology and Immunology, Harvard Medical School, Boston MA, USA
Genetic informationTg(Cd74-rtTA)#Doi: The Cd74 promoter, together with the H2-Ea enhancer, drives the expression of an improved reverse tet transactivator, rtTA-S2. Four independent lines were produced. An un-named line showing the lowest liver expression was used. Tg(tetO-Cd74/MCC)#Doi: Seven tetO sequences were combined with the CMV minimal promoter to drive expression, when induced by doxycycline, of a construct composed of the Cd74 cDNA and a segment of moth cytocrome c cDNA encoding amino acid residues 93 to 103, which replace the CLIP region of Cd74 (amino acid residues 88 to 98).
Phenotypic informationBoth transgenes confer inducibility of the moth cytochrome C antigen presented by H-2Ek following doxycyclin administration, mostly by dendritic cells.
Breeding historyBackcrossed more than 10 generations to B10.BR-H2k H2-T18a/SgSnJ. Currently brother x sister matings. C57BL/6 or C57BL/10 best conventional background usable for this line.
References
  • Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.;Obst Reinhard, van Santen Hisse-Martien, Mathis Diane, Benoist Christophe, ;2005;The Journal of experimental medicine;201;1555-65; 15897273
  • Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.;van Santen Hisse-Martien, Benoist Christophe, Mathis Diane, ;2004;The Journal of experimental medicine;200;1221-30; 15534371
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous B10.BR-H2k, wild-type C57BL/6J
Stage of embryos2-cell

Literature references

  • Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.;Obst Reinhard, van Santen Hisse-Martien, Mathis Diane, Benoist Christophe, ;2005;The Journal of experimental medicine;201;1555-65; 15897273
  • Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.;van Santen Hisse-Martien, Benoist Christophe, Mathis Diane, ;2004;The Journal of experimental medicine;200;1221-30; 15534371

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).